Cardiorentis' Series B Round

Cardiorentis raised a round of funding on January 11, 2016.

Cardiorentis is a biopharmaceutical company that is committed to bringing novel therapies to the treatment of heart failure and related cardiovascular diseases. The company's disease-based technology …

Articles about Cardiorentis' Series B Round: